MedTech News
.................... by Andrew Celentano

MedCAD’s AccuStride® Receives FDA 510(k) Clearance for New Anatomical Lower Leg Region Tib/Fib Solution
DALLAS, April 8, 2026 /PRNewswire/ — Dallas-based MedCAD has received FDA 510(k) clearance of its AccuStride® lower leg tibia and fibula system, making these patient-specific precision devices available to surgeons. The unique design of the custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.

Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
Sabrina Martucci Johnson wants everyone to invest in her women’s health biotech Daré Bioscience. That means you, dear reader.

FDA approves Endospan’s aortic stent
Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around 25% of patients are diagnosed or treated.

Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.

BD picks up CE mark for next-gen stent graft
BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system.

Supira gets FDA green light to conduct ventricular assist device study
Supira Medical announced today that it received FDA approval to initiate a new trial of its percutaneous ventricular assist device (pVAD).

MRI technique enables long-term tracking of transplanted stem cell-derived heart cells
Researchers at the Institute of Biomedical Engineering at the University of Toronto have demonstrated a new way to monitor transplanted stem-cell-derived heart cells using magnetic resonance imaging (MRI).

Gene-edited stem cells help five blood disorder patients stop transfusions in clinical trial
Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia.